Please assess the completion status of the following clinical trial:

Trial Title: EIMD Mechanisms Causing Force Loss

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* age range of 18-35 years of age~* males and females who do not have a history of orthopedic injuries of the hip knee, and/or leg~* Participants must be engaged in some form of physical activity on at least 3 days each week~Exclusion Criteria:~* An answer of yes to any of the seven questions on the physical activity readiness questionnaire (PAR-Q)~* Average daily consumption of more than 40mg of caffeine per day as determined by the 2 week caffeine recall questionnaire~* Use of any type of prescription psychiatric or prescription or over-the-counter pain medication~* An answer of yes to questions 1,2,8, and 15-22 on the rhabdomyolysis screening questionnaire~* An answer of yes on questions 3,4,6,7,8, 11,12, and 13 if the follow up information indicates any type of medication, drug, supplement, illness, and/or dietary need that could affect pain sensitivity or the risk of dehydration. Determinations will be made on a participant-by-participant basis depending on the answers provided~* An answer of yes on question 24 indicating a previous adverse reaction to caffeine consumption~* Resting systolic blood pressure \>140 mmHg and/or resting diastolic blood pressure \>90 mmHg~* Pregnancy or suspicion of pregnancy.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 35 Years
- Healthy Volunteers: t

Study Arms:
- Caffeine Pill (Type: ACTIVE_COMPARATOR): The caffeine will be administered.
- Placebo/Flour Pill (Type: PLACEBO_COMPARATOR): The flour will be administered.

Based on this trial design, predict the completion outcome and termination type (if applicable).